Effect of Synbiotic as an Adjuvant Therapy in the Treatment of Parkinson's Disease
Recruiting · NCT05576818 · Interventional (participants receive a specific treatment) · Lead sponsor: Tanta University
View the official record on ClinicalTrials.gov →Interventions studied
Lactobacillus acidophilus 10 billion colony forming unit (CFU) and prebiotic fibers
What this trial is about
This study aims to investigate the possible efficacy and safety of synbiotic preparation of Lactobacillus acidophilus probiotic with prebiotic fibers as an adjuvant therapy in the treatment of Parkinson's disease
Who can take part
Age range
45 Years to 65 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Phase 3
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Age between 45 and 65 years old
- Both sexes
- Patients with Parkinson's disease on dopamine replacement therapy
- Modified Hoehn and Yahr stage, MHY 1-4
Exclusion criteria
- Patients who are currently using or used antibiotics therapy in the preceding month
- Patients who are currently using or used other probiotic products in the preceding two weeks
- Patients scheduled to undergo GIT surgery or those underwent GIT surgery
- Patients with Known allergy to probiotics
- Patients receiving artificial enteral or intravenous nutrition
- Patients with depression and/or psychosis
- Patients taking antioxidant and/or anti-inflammatory medications
- Patients with Hyperthyroidism
- Patients with inflammatory condition and/or condition involving oxidative stress
- Smokers
- Modified Hoehn \& Yahr stage MHY 5
Where it is running
1 location listed.
- Tanta University - Tanta, El Gharbia, Egypt